Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Endostatins Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Kai Li
19952019
No photo of Daliang Qi
20052017

Research Output 1995 2019

Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303

Si, X., Zhang, L., Wang, H., Zhang, X., Wang, M., Han, B., Li, K., Wang, Q., Shi, J., Wang, Z., Cheng, Y., Shi, Y., Chen, W., Wang, X., Luo, Y., Nan, K. & Jin, F., Jan 1 2019, (Accepted/In press) In : Thoracic Cancer.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Patient Education
Placebos
Hand-Foot Syndrome
Proto-Oncogene Proteins c-kit
1 Citations

A case report of advanced lung adenocarcinoma harboring KRAS mutation treated with anlotinib

Su, Y., Meng, Z., Xu, X., Wang, X., Zuo, R., Hou, Y., Li, K. & Chen, P., Jan 1 2018, In : Chinese Journal of Lung Cancer. 21, 5, p. 428-430 3 p.

Research output: Contribution to journalArticle

Mutation
Non-Small Cell Lung Carcinoma
Therapeutics
Platelet-Derived Growth Factor Receptors
Fibroblast Growth Factor Receptors
10 Citations

Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: A multicentre, randomised phase II trial (ALTER0302)

Han, B., Li, K., Zhao, Y., Li, B., Cheng, Y., Zhou, J., Lu, Y., Shi, Y., Wang, Z., Jiang, L., Luo, Y., Zhang, Y., Huang, C., Li, Q. & Wu, G., Mar 6 2018, In : British journal of cancer. 118, 5, p. 654-661 8 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Confidence Intervals
Placebos
Disease-Free Survival
Therapeutics